Table: SymBio Pharmaceuticals -2020 parent results

SymBio Pharmaceuticals

04/02/2021 06:30

Feb 4 (Reuters)- 
          SymBio Pharmaceuticals Limited 
          PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                  Year ended       Year ended       Year to       NEXT   
               Dec 31, 2020     Dec 31, 2019   Dec 31, 2021     YEAR     
                  LATEST          YEAR-AGO        COMPANY      COMPANY   
                 RESULTS          RESULTS        FORECAST    H1 FORECAST 
  Sales            2.99             2.84           9.15                  
                (+5.3 pct)      (-26.0 pct)    (+206.4 pct)              
  Operating     loss 4.51        loss 4.30         1.36                  
  Recurring     loss 4.62        loss 4.38         1.35                  
  Net           loss 4.09        loss 4.38         1.15                  
  EPS        loss 124.13 yen  loss 189.03 yen    30.10 yen               
  Ann Div          NIL              NIL             NIL                  
  -Q2 Div          NIL              NIL             NIL                  
  -Q4 Div          NIL              NIL             NIL                  
  
  NOTE - SymBio Pharmaceuticals Limited. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4582.T